InvestorsHub Logo
Followers 6
Posts 1087
Boards Moderated 0
Alias Born 07/18/2006

Re: None

Tuesday, 01/26/2021 11:29:50 AM

Tuesday, January 26, 2021 11:29:50 AM

Post# of 17422
Canadian AF Doppelganger has struck with a vengeance!

What follows is some incredible BS. How much did he get paid?

Assuming he had to be paid since no one could be this stupid!


Mackie Research #Downgrading AUPH from a SPECULATIVE BUY to a HOLD Rating Despite the FDA Approved Lupkynis (voclosporin) for Lupus Nephritis target price of US$17.90/share

The FDA approval of Lupkynis is certainly a big win for AUPH. However, we believe it is prudent to stand on the sidelines for now as the market likely has fully factored in the near term Lupkynis commercialization.


Expecting some followup stating that Mackie Research has been downgraded to avoid like the plague (or Covid)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News